When is the 레메디 IPO subscription?

Wed Jul 1 to Thu Jul 2 (Korea time). Refunds and payment are on Mon Jul 6.

What is the 레메디 IPO price?

₩20,700 per share. The indicative range was ₩17,800-20,700, and the price was set at the top of the range.

What was the 레메디 book-building demand ratio?

2,246 institutional bids produced a demand ratio of 1,146.41 : 1; lock-up commitments covered 17.9% of bid volume.

When does 레메디 list on the Korean stock market?

Trading is scheduled to start on Mon Jul 13, per the issuance result report filed with DART.

레메디 IPO

Listed

한국어 DART filing

Offer price₩20,700Final terms filed

Shares offered1,200,000

Offering size₩24.8bn

SubscriptionWed Jul 1

레메디 IPO subscription runs Wed Jul 1 to Thu Jul 2. The offer price is ₩20,700 for 1,200,000 shares, about ₩24.8bn in total. Underwriters: KB Securities. Payment and refund date: Mon Jul 6. Trading is scheduled to start on Mon Jul 13. Institutional book-building drew 2,246 bids for a demand ratio of 1,146.41 : 1, with lock-up commitments on 17.9% of bid volume, and the price was set at the top of the range at ₩20,700. The retail subscription ratio was 1,706.71 : 1 across 316,557 applications.

Book-building and subscription results

All IPO results

Institutional demand ratio1,146.41 : 12,246 bids · 1,031,768,000 shares

Lock-up commitments17.9%share of bid volume

Final offer price₩20,700range 17,800~20,700 · at the top of the range

Retail subscription ratio1,706.71 : 1316,557 applications

Subscribed amount₩5.30tnshares applied × offer price

Figures from the DART final terms filing · issuance result report. Demand ratios are simple ratios of shares bid to shares allocated and do not show real demand for the stock. Not investment advice.

A demand ratio of 1,146.41 : 1 ranks 12 of the last 35 Korean IPOs with published results, where the median is 1,000.07 : 1. A high demand ratio does not predict the listing-day move. See Korea IPO demand results.

Underwriters

Role	Broker	Shares	Amount
Lead	KB Securities	1,200,000	₩21.4bn

레메디 IPO FAQ

When is the 레메디 IPO subscription?: Wed Jul 1 to Thu Jul 2 (Korea time). Refunds and payment are on Mon Jul 6.
What is the 레메디 IPO price?: ₩20,700 per share. The indicative range was ₩17,800-20,700, and the price was set at the top of the range.
What was the 레메디 book-building demand ratio?: 2,246 institutional bids produced a demand ratio of 1,146.41 : 1; lock-up commitments covered 17.9% of bid volume.
When does 레메디 list on the Korean stock market?: Trading is scheduled to start on Mon Jul 13, per the issuance result report filed with DART.
What was the 레메디 retail subscription ratio?: 1,706.71 : 1 across 316,557 applications.

From the DART registration statement (equity securities). Book-building and subscription results are added once the final terms filing and issuance result report are published; listing dates are not included. Not investment advice.